Rautemaa R - Search Results

1

Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I.

Husebye ES, Perheentupa J, Rautemaa R, Kämpe O. Husebye ES, et al. Among authors: rautemaa r. J Intern Med. 2009 May;265(5):514-29. doi: 10.1111/j.1365-2796.2009.02090.x. J Intern Med. 2009. PMID: 19382991 Free article. Review.

2

Oral and oesophageal squamous cell carcinoma--a complication or component of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED, APS-I).

Rautemaa R, Hietanen J, Niissalo S, Pirinen S, Perheentupa J. Rautemaa R, et al. Oral Oncol. 2007 Jul;43(6):607-13. doi: 10.1016/j.oraloncology.2006.07.005. Epub 2006 Sep 25. Oral Oncol. 2007. PMID: 16997613

3

Decreased susceptibility of Candida albicans to azole antifungals: a complication of long-term treatment in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients.

Rautemaa R, Richardson M, Pfaller M, Koukila-Kähkölä P, Perheentupa J, Saxén H. Rautemaa R, et al. J Antimicrob Chemother. 2007 Oct;60(4):889-92. doi: 10.1093/jac/dkm299. Epub 2007 Aug 17. J Antimicrob Chemother. 2007. PMID: 17704513

4

Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasis.

Rautemaa R, Richardson M, Pfaller MA, Perheentupa J, Saxén H. Rautemaa R, et al. Diagn Microbiol Infect Dis. 2008 Oct;62(2):182-5. doi: 10.1016/j.diagmicrobio.2008.05.007. Epub 2008 Jul 1. Diagn Microbiol Infect Dis. 2008. PMID: 18597968

5

Reduction of fluconazole susceptibility of Candida albicans in APECED patients due to long-term use of ketoconazole and miconazole.

Rautemaa R, Richardson M, Pfaller M, Perheentupa J, Saxen H. Rautemaa R, et al. Scand J Infect Dis. 2008;40(11-12):904-7. doi: 10.1080/00365540802275853. Scand J Infect Dis. 2008. PMID: 18651265

6

Candida albicans isolates from APECED patients show decreased susceptibility to miconazole.

Siikala E, Richardson M, Pfaller MA, Diekema DJ, Messer SA, Perheentupa J, Saxén H, Rautemaa R. Siikala E, et al. Among authors: rautemaa r. Int J Antimicrob Agents. 2009 Dec;34(6):607-9. doi: 10.1016/j.ijantimicag.2009.07.007. Epub 2009 Sep 11. Int J Antimicrob Agents. 2009. PMID: 19748230 No abstract available.

7

Expression of alpha-defensin-1 in chronic hyperplastic candidosis.

Ali A, Niissalo S, Hietanen J, Laine M, Rautemaa R, Konttinen Y. Ali A, et al. Among authors: rautemaa r. J Oral Pathol Med. 2005 Jul;34(6):347-51. doi: 10.1111/j.1600-0714.2005.00317.x. J Oral Pathol Med. 2005. PMID: 15946182

8

A possible CD1a Langerhans cell-mast cell interaction in chronic hyperplastic candidosis.

Ali A, Rautemaa R, Hietanen J, Beklen A, Konttinen Y. Ali A, et al. Among authors: rautemaa r. J Oral Pathol Med. 2007 Jul;36(6):329-36. doi: 10.1111/j.1600-0714.2007.00527.x. J Oral Pathol Med. 2007. PMID: 17559493

9

Expression of interleukin-8 and its receptor IL-8RA in chronic hyperplastic candidosis.

Ali A, Rautemaa R, Hietanen J, Järvensivu A, Richardson M, Konttinen YT. Ali A, et al. Among authors: rautemaa r. Oral Microbiol Immunol. 2006 Aug;21(4):223-30. doi: 10.1111/j.1399-302X.2006.00280.x. Oral Microbiol Immunol. 2006. PMID: 16842506

10

Candida yeasts in chronic periodontitis tissues and subgingival microbial biofilms in vivo.

Järvensivu A, Hietanen J, Rautemaa R, Sorsa T, Richardson M. Järvensivu A, et al. Among authors: rautemaa r. Oral Dis. 2004 Mar;10(2):106-12. doi: 10.1046/j.1354-523x.2003.00978.x. Oral Dis. 2004. PMID: 14996281

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page